GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Revenue of GeneDx Holdings Corp. (WGS)
Revenue in 2023 (TTM): $202.57 M
According to GeneDx Holdings Corp.'s latest financial reports the company's current revenue (TTM) is $202.57 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of GeneDx Holdings Corp.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $202.57 M | $60.62 M | $-136,460,000 | $-176,693,000 | $-175,767,000 |
| 2022 | $234.69 M | $-26,750,000 | $-398,198,000 | $-598,032,000 | $-548,980,000 |
| 2021 | $212.2 M | $-16,602,000 | $-219,193,000 | $-245,390,000 | $-245,390,000 |
| 2020 | $179.32 M | $4.03 M | $-224,732,000 | $-241,340,000 | $-246,436,000 |
| 2019 | $196.17 M | $82.79 M | $-22,514,000 | $-29,704,000 | $-30,991,000 |